Financial Instruments and Risk Management (Tables)

6 Months Ended

Jun. 30, 2011

Financial Instruments and Risk Management

Derivatives Designated as Hedging Instruments Fair Values of Derivative Instruments

	Asset Derivatives
	June 30, 2011			December 31, 2010
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
(In thousands)
Foreign currency forward contracts	Prepaid expenses and other current assets	$	15,221	Prepaid expenses and other current assets	$	8,884
Total		$	15,221		$	8,884
	Liability Derivatives
	June 30, 2011			December 31, 2010
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
(In thousands)
Interest rate swaps	Other current liabilities	$	21,078	Other current liabilities	$	25,666
Foreign currency borrowings	Long-term debt		986,209	Long-term debt		909,255
Total		$	1,007,287		$	934,921

Derivatives Not Designated as Hedging Instruments Fair Values of Derivative Instruments

	Asset Derivatives
	June 30, 2011			December 31, 2010
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
(In thousands)
Foreign currency forward contracts	Prepaid expenses and other current assets	$	2,733	Prepaid expenses and other current assets	$	10,993
Purchased cash convertible note hedge	Other assets		581,400	Other assets		472,400
Total		$	584,133		$	483,393
	Liability Derivatives
	June 30, 2011			December 31, 2010
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
(In thousands)
Foreign currency forward contracts	Other current liabilities	$	1,735	Other current liabilities	$	7,729
Cash conversion feature of Cash Convertible Notes	Long-term debt		581,400	Long-term debt		472,400
Total		$	583,135		$	480,129

Effect of Derivative Instruments on Condensed Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships

	Location of Gain or (Loss) Recognized in Earnings on Derivatives	Amount of Gain or (Loss) Recognized in Earnings on Derivatives
		Three Months Ended June  30,					Six Months Ended June  30,
		2011			2010		2011			2010
(In thousands)
Interest Rate Swaps	Interest Expense	$	11,123		$	—	$	4,795		$	—
Total		$	11,123		$	—	$	4,795		$	—
		Amount of Gain or (Loss) Recognized in Earnings on Hedged Items
	Location of Gain or (Loss) Recognized in Earnings on Hedged Items	Three Months Ended June 30,					Six Months Ended June 30,
		2011			2010		2011			2010
(In thousands)
2018 Senior Notes	Interest Expense	$	(11,123	)	$	—	$	(4,795	)	$	—
Total		$	(11,123	)	$	—	$	(4,795	)	$	—

Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships

The Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations

Derivatives in Cash Flow Hedging Relationships

	Amount of Gain or (Loss) Recognized in AOCE (Net of Tax) on Derivative (Effective Portion)
	Three Months Ended June 30,					Six Months Ended June 30,
	2011		2010			2011		2010
(In thousands)
Foreign currency forward contracts	$	301	$	(7,748	)	$	1,689	$	(2,863	)
Interest rate swaps		568		(971	)		2,889		3,041
Total	$	869	$	(8,719	)	$	4,578	$	178

	Location of Gain or (Loss) Reclassified from AOCE into Earnings (Effective Portion)	Amount of Gain or (Loss) Reclassified from AOCE into Earnings (Effective Portion)
		Three Months Ended June 30,						Six Months Ended June 30,
		2011			2010			2011			2010
(In thousands)
Foreign currency forward contracts	Net revenues	$	1,622		$	468		$	2,367		$	879
Interest rate swaps	Interest expense		(407	)		(6,271	)		(2,189	)		(22,358	)
Total		$	1,215		$	(5,803	)	$	178		$	(21,479	)
	Location of Gain or (Loss) Excluded from the Assessment of Hedge Effectiveness	Amount of Gain or (Loss) Excluded from the Assessment of Hedge Effectiveness
		Three Months Ended June 30,						Six Months Ended June 30,
		2011			2010			2011			2010
(In thousands)
Foreign currency forward contracts	Other income (expense), net	$	5,054		$	1,250		$	5,088		$	1,250
Total		$	5,054		$	1,250		$	5,088		$	1,250

Effect of Derivative Instruments on the Condensed Consolidated Statement of Operations Derivatives in Net Investment Hedging Relationships

	Amount of Gain or (Loss) Recognized in AOCE (Net of Tax) on Derivative (Effective Portion)
	Three Months Ended June 30,					Six Months Ended June 30,
	2011			2010		2011			2010
(In thousands)
Foreign currency borrowings	$	(13,577	)	$	53,394	$	(47,296	)	$	89,058
Total	$	(13,577	)	$	53,394	$	(47,296	)	$	89,058

Effect of Derivative Instruments on the Condensed Consolidated Statement of Operations Derivatives Not Designated as Hedging Instruments

(In thousands)	Location of Gain or (Loss) Recognized in Earnings on Derivatives	Amount of Gain or (Loss) Recognized in Earnings on Derivatives
		Three Months Ended June 30,						Six Months Ended June 30,
		2011			2010			2011			2010
Foreign currency forward contracts	Other income (expense), net	$	2,682		$	(8,210	)	$	14,144		$	(23,151	)
Cash conversion feature of
Cash Convertible Notes	Other income (expense), net		(59,700	)		183,800			(109,000	)		62,700
Purchased cash convertible note hedge	Other income (expense), net		59,700			(183,800	)		109,000			(62,700	)
Total		$	2,682		$	(8,210	)	$	14,144		$	(23,151	)

Financial Assets and Liabilities Carried at Fair Value

	June 30, 2011
	Level 1		Level 2		Total
	(In thousands)
Financial Assets:
Trading securities:
Equity securities — exchange traded funds	$	6,400	$	—	$	6,400
Total trading securities		6,400		—		6,400
Available-for-sale fixed income investments:
U.S. Treasuries		—		12,324		12,324
Corporate bonds		—		7,761		7,761
Agency mortgage-backed securities		—		1,736		1,736
Other		—		2,703		2,703
Total available-for-sale fixed income investments		—		24,524		24,524
Available-for-sale equity securities:
Biosciences industry		275		—		275
Total available-for-sale equity securities		275		—		275
Foreign exchange derivative assets		—		17,954		17,954
Purchased cash convertible note hedge		—		581,400		581,400
Total assets at fair value (1) (2)	$	6,675	$	623,878	$	630,553
Financial Liabilities:
Foreign exchange derivative liabilities	$	—	$	1,735	$	1,735
Interest rate swap derivative liabilities		—		21,078		21,078
Cash conversion feature of cash convertible notes		—		581,400		581,400
Total liabilities at fair value (1) (2)	$	—	$	604,213	$	604,213

	December 31, 2010
	Level 1		Level 2		Total
	(In thousands)
Financial Assets:
Trading securities:
Equity securities — exchange traded funds	$	3,693	$	—	$	3,693
Total trading securities		3,693		—		3,693
Available-for-sale fixed income investments:
U.S. Treasuries		—		12,387		12,387
Corporate bonds		—		8,116		8,116
Agency mortgage-backed securities		—		1,934		1,934
Other		—		2,573		2,573
Total available-for-sale fixed income investments		—		25,010		25,010
Available-for-sale equity securities:
Biosciences industry		382		—		382
Total available-for-sale equity securities		382		—		382
Foreign exchange derivative assets		—		19,877		19,877
Purchased cash convertible note hedge		—		472,400		472,400
Total assets at fair value (1) (2)	$	4,075	$	517,287	$	521,362
Financial Liabilities:
Foreign exchange derivative liabilities	$	—	$	7,729	$	7,729
Interest rate swap derivative liabilities		—		25,666		25,666
Cash conversion feature of cash convertible notes		—		472,400		472,400
Total liabilities at fair value (1) (2)	$	—	$	505,795	$	505,795

⁽¹⁾  The Company chose not to elect the fair value option for its financial assets and liabilities that had not been previously carried at fair value. Therefore, material financial assets and liabilities not carried at fair value, such as short-term and long-term debt obligations and trade accounts receivable and payable, are still reported at their carrying values.

⁽²⁾  None of the Company's financial assets and liabilities measured at fair value on a recurring basis are valued using Level 3 inputs as of June 30, 2011 or December 31, 2010.